The biology and tumour-related properties of monocyte tissue factor

被引:0
|
作者
Lwaleed, BA
Bass, PS
Cooper, AJ
机构
[1] Univ Southampton, Southampton Gen Hosp, Dept Haematol, Southampton SO16 6YD, Hants, England
[2] Southampton Univ Hosp, Dept Histopathol, Southampton SO16 6YD, Hants, England
[3] Southampton Univ Hosp, Dept Urol, Southampton SO16 6YD, Hants, England
来源
JOURNAL OF PATHOLOGY | 2001年 / 193卷 / 01期
关键词
tissue factor; tumour biology; monocyte tissue factor; causes of expression; clinical significance; review;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tissue factor (TF, coagulation factor III, CD142) is not only the main physiological initiator of normal blood coagulation, but is also important in the natural history of solid malignancies in that it potentiates metastasis and angiogenesis and mediates outside-in signalling. TF is expressed constitutively by many tissues which are not in contact with blood and by other cells upon injury or activation; the latter include endothelial cells, tissue macrophages, and peripheral blood monocytes, It can exist encrypted and unavailable functionally in the plasma membrane and the appearance of functional TF may be due to synthesis and/or de-encryption. Inflammatory cells often express TF and act to induce its production or de-encryption by other cells locally and, apparently, at remote sites. Inappropriate expression of TF by endothelial cells, macrophages or monocytes is thought to be an important trigger of coagulation in various pathological conditions, Several studies have shown that measurements of monocyte TF (mTF) may provide clinically significant information, particularly in patients with malignant and inflammatory diseases. Copyright (C) 2000 John Wiley & Sons, Ltd.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 50 条
  • [1] The Constellation of Risk Factors and Paraneoplastic Syndromes in Cholangiocarcinoma: Integrating the Endocrine Panel Amid Tumour-Related Biology (A Narrative Review)
    Ciobica, Mihai-Lucian
    Sandulescu, Bianca-Andreea
    Chicea, Liana-Maria
    Iordache, Mihaela
    Groseanu, Maria-Laura
    Carsote, Mara
    Nistor, Claudiu
    Radu, Ana-Maria
    BIOLOGY-BASEL, 2024, 13 (09):
  • [2] Injury induces increased monocyte expression of tissue factor: Factors associated with head injury attenuate the injury-related monocyte expression of tissue factor
    Utter, GH
    Owings, JT
    Jacoby, RC
    Gosselin, RC
    Paglieroni, TG
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2002, 52 (06): : 1071 - 1077
  • [3] Monocyte tissue factor levels in patients with urological tumours: an association between tumour presence and progression
    Lwaleed, BA
    Francis, JL
    Chisholm, M
    BJU INTERNATIONAL, 1999, 83 (04) : 476 - 482
  • [4] Structural biology of factor VIIa/tissue factor initiated coagulation
    Vadivel, Kanagasabai
    Bajaj, S. Paul
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2012, 17 : 2476 - 2494
  • [5] Tissue factor in tumour progression
    Rak, Janusz
    Milsom, Chloe
    Magnus, Nathalie
    Yu, Joanne
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2009, 22 (01) : 71 - 83
  • [6] Tissue factor, angiogenesis and tumour progression
    Joanne E Bluff
    Nicola J Brown
    Malcolm WR Reed
    Carolyn A Staton
    Breast Cancer Research, 10
  • [7] PRODUCTION OF TISSUE FACTOR BY MONOCYTE PROGENITOR CELLS
    STEPHENS, AC
    ZHENG, RQH
    RUSSELL, ARB
    LEVIN, M
    RIVERS, RPA
    THROMBOSIS RESEARCH, 1994, 76 (01) : 33 - 45
  • [8] Monocyte tissue factor levels in cancer patients
    Lwaleed, BA
    Francis, JL
    Chisholm, M
    SAUDI MEDICAL JOURNAL, 2000, 21 (08) : 722 - 729
  • [9] Notes on the cell biology of tissue factor
    Camerer, E
    Prydz, H
    HAEMOSTASIS, 1996, 26 : 25 - 30
  • [10] Monocyte tissue factor response is decreased in patients with hyperlipidemia
    Rugeri, L
    Susen, S
    Bard, JM
    Corseaux, D
    Gavériaux, V
    Devos, P
    Lecerf, JM
    Duriez, P
    Jude, B
    THROMBOSIS RESEARCH, 1999, 96 (04) : 283 - 292